Last updated: 2026-10-09 20:20:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Zhengye Biotechnology Holding Limited (ZYBT) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1,72, with a market capitalization of $54,97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,62 to $8,01. This page covers its latest market performance, valuation, price trends and company information.
$54,97M | |
$1,19 | |
$14,30 | |
$0,62 | |
$1,15 | |
19,41M | |
5,19M | |
-- | |
$8,01 | |
$0,62 | |
-- | |
-- |
Zhengye Biotechnology Holding Limited (ZYBT) is trading at $2,45 in after-hours trading as of 2026-10-09 20:19:00, up 112,89% ($1,30) from the regular-session close of $1,15.
After-hours trading shows how investors are pricing ZYBT after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Zhengye Biotechnology Holding Limited (ZYBT) moved from $1,20 to $1,72, representing a gain of 43,25% ($0,52).
The stock traded between $1,09 and $2,79 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 21,20 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 14,9%
ZYBT is currently trading at $1,72, placing it 14,9% of the way from its 52-week low of $0,62 to its 52-week high of $8,01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
| Employees | 269 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Zhengye Biotechnology Holding Limited (ZYBT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.